Home / Medicine / Aldactone(spironolactone)

Aldactone(spironolactone)

Marketed in 39 countries across Europe, the Americas, the Middle East, and the Asia-Pacific region, Aldactone is a globally distributed brand of spironolactone, classified as a potassium-sparing diuretic with hypotensive properties. For an international audience, the brand is one of the more recognisable names in this particular corner of the diuretic class, and travellers who have been prescribed it at home will often find either Aldactone itself or a spironolactone generic available in the country they are visiting.

Spironolactone is prescribed in the management of several distinct clinical situations: cirrhosis and ascites, primary and secondary hyperaldosteronism, nephrotic syndrome, and the prevention or correction of hypokalaemia in patients on other diuretics. The structured indication block further down this page sets out each registered use in detail, alongside the full country list and the pharmacological classification.

Because Aldactone has such a broad regulatory footprint — with marketing authorisation in markets as varied as Brazil, Germany, India, Canada, and Egypt — the brand name on the box may be Aldactone in one country and a different spironolactone-containing product in the next. Packaging, prescription pathways, and which strengths are stocked routinely all vary by jurisdiction, and a local pharmacist is usually the fastest route to confirming whether a familiar molecule is sitting on the shelf under an unfamiliar label.

Other medications within the broader diuretic family, including other potassium-sparing agents, are also available internationally under their own active ingredients and brand names, though they are not interchangeable without clinical input. Anyone who takes Aldactone, has been newly prescribed it abroad, or is trying to identify a local equivalent should treat the question as a clinical one and discuss it with a healthcare provider.

Shelf life

5 years.

Incompatibilities

Not applicable.

Date of revision of the text

04/2018

Marketing authorisation holder

Pfizer Limited

Ramsgate Road

Sandwich

Kent, CT13 9NJ

United Kingdom

Special precautions for storage

Do not store above 30°C.

Nature and contents of container

Amber glass or plastic bottles containing 100 or 500 tablets.

HDPE containers of 50 or 1,000 tablets.

PVC/foil blister packs containing 100 or 500 tablets and PVC/foil blister calendar pack of 28 tablets.

Not all pack sizes may be marketed.

Marketing authorisation number(s)

PL 00057/0927

Special precautions for disposal and other handling

No special requirements for disposal.

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

Date of first authorisation/renewal of the authorisation

Date of change of ownership: 16 September 2014

Date of latest renewal: 7 February 2002

Frequently asked questions

What conditions does Aldactone treat?

Aldactone is prescribed in the management of cirrhosis with ascites, primary hyperaldosteronism, other forms of hyperaldosteronism, nephrotic syndrome, and hypokalaemia — including the prevention of low potassium in patients taking other diuretics. The active ingredient is classified as a potassium-sparing diuretic with hypotensive properties. The structured indication list below this introduction details each registered use across the markets where Aldactone is sold.

Which active substance is in Aldactone?

Aldactone contains spironolactone, a potassium-sparing diuretic that also has hypotensive activity. Spironolactone is the same molecule whether it appears under the Aldactone brand or as a generic, and internationally the active ingredient circulates under a number of different commercial names, particularly in markets where the original patent has long expired and several manufacturers produce spironolactone products in parallel.

In how many countries is Aldactone available?

Aldactone carries marketing authorisation in 39 countries, spanning Europe, the Americas, the Middle East, South Asia, and the Asia-Pacific. Examples from the registered list include Brazil, Germany, India, Canada, Egypt, Australia, France, and Hong Kong. If your country is not represented here, a local pharmacist can usually confirm whether spironolactone is available in that market under a different brand or as a generic.

Can I find a generic version of Aldactone?

Spironolactone is widely available internationally under several brand names and as a generic, particularly in markets where the original patent has expired. Other medications within the broader diuretic class — including other potassium-sparing agents — also exist, although they are not interchangeable without clinical guidance. To find a local spironolactone-containing product, search the active ingredient on Pill2Trip or ask a pharmacist in your country.

Is Aldactone a prescription medication?

Yes. Aldactone is a prescription medication in the markets where it is registered, and the conditions it is used for — including cirrhosis, hyperaldosteronism, and electrolyte management — are all situations that require clinical supervision. Prescription rules, available strengths, and even which generics are stocked vary between countries, which matters particularly for travellers and people relocating. Any decision to start, stop, or switch should involve a healthcare provider.